Vaccination News Home Page

http://bmj.com/cgi/content/full/324/7347/1175/a

PDF of this article Email this article to a friend Respond to this article PubMed citation Related articles in PubMed Download to Citation Manager Search Medline for articles by: Dobson, R. Alert me when: New articles cite this article

Collections under which this article appears: Drugs: respiratory system

BMJ 2002;324:1175 ( 18 May )

News

Trial shows azithromycin is no better than vitamin C for bronchitis

Roger Dobson, Abergavenny

An antibiotic commonly prescribed for acute bronchitis is no better than low doses of vitamin C, according to new research.

A double blind, randomised controlled trial has concluded that azithromycin is ineffective and should not be prescribed for acute bronchitis.

A report of the research (Lancet 2002;359:1648-54) says that every year in the United States some 10 million adults seek treatment for acute bronchitis and that most of them are given antibiotics, although the pathogens involved are viruses in most cases.

"Many experts condemn such treatment, citing three main reasons: weak or conflicting experimental evidence of clinical benefit; lack of a strong biological rationale; and increasing societal concerns about widespread antibiotic resistance," says the report.

The researchers, from Cook County Hospital, Chicago, and elsewhere, set out to compare the benefits of azithromycin with the benefits achieved with capsules of vitamin C.

"We chose vitamin C instead of a traditional placebo because the results of several focus groups we undertook showed that people would probably refuse to take part in any randomised trial of acute bronchitis if the placebo group received a sugar pill. They suggested that a randomised trial of antibiotics and a multivitamin or some other vitamin pill would be acceptable," say the researchers.

Around 200 patients with acute bronchitis but without evidence of underlying lung disease took part in the trial. Measures used to compare the effects of the two treatments included time taken to return to work or usual activities and improvements in health related quality of life.

"These results show that azithromycin is no more effective than low-dose vitamin C for treatment of acute bronchitis. Given the lack of evidence that low-dose vitamin C is beneficial, we conclude that azithromycin is ineffective and should not be prescribed for patients with acute bronchitis," says the report.

Researchers recommend that azithromycin, which is marketed as Zithromax in the United Kingdom, should not be prescribed for acute bronchitis

© BMJ 2002
 

PDF of this article Email this article to a friend Respond to this article PubMed citation Related articles in PubMed Download to Citation Manager Search Medline for articles by: Dobson, R. Alert me when: New articles cite this article

Collections under which this article appears: Drugs: respiratory system

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.